The letters alleged that some of the words used in advertising the products gave rise to an Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers over the Internet. The FDA demanded immediate action, suggesting the online marketers cease and desist from using the language cited in the FDAs warning letter from their online advertising
Its important to note that if these medications are stopped, weight regain is commonso well work with you to create a sustainable, long-term plan that may include ongoing therapy, lifestyle changes, and family support
If you have questions, please contact your Fisher Phillips attorney, the authors of this Insight, any attorney in our Employee Benefits and Tax Practice Group
3 GLP-1s are multi-system therapies
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
It is started at a lower dose and then gradually increased over the weeks
